2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1902895998 M.D.
Verify on CMS →

ALAN ULISS, M.D.

Retina Specialist (Ophthalmology) Physician in FOREST HILLS, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 771 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]

What the federal data shows

ALAN ULISS, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 4,021 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
4K
Part D claims, 2023
48%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ALAN ULISS, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ALAN ULISS, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ALAN ULISS, M.D.?

Below national average

NPI registry status

Active

Issued 10/21/2005

NPI 1902895998

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

4,021 621% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Retina Specialist (Ophthalmology) Physician compares to other specialties among New York providers

New York providers

Retina Specialist (Ophthalmology) Physician share within New York

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within New York

Medicare quality performance — MIPS

ALAN ULISS, M.D.'s 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ALAN ULISS, M.D. appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding M.D. credentials at 11011 72ND AVE, FOREST HILLS, NY, 11375, with a listed phone of (718) 575-8434. NPI 1902895998 was issued on 10/21/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ULISS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,021 prescription claims written by this provider, covering 771 Medicare beneficiaries and totaling roughly $951K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11011 72ND AVE
FOREST HILLS, NY 11375

Provider Details

NPI 1902895998
Specialty Retina Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Male
NPI Issued 10/21/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ALAN ULISS, M.D.. To verify ALAN ULISS, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

ALAN ULISS, M.D. — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 4,021 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,021
Total Claims
$951K
Total Drug Cost
771
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,706
Total Day Supply
224,136
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$872K
Generic Drug Cost
$79K
Antibiotic Claims
14

Patient Demographics

Average Patient Age
77.2 years
Avg HCC Risk Score
1.51
Gender Split
64% female / 36% male
Age Distribution
<65: 32, 65-74: 266, 75-84: 312, 85+: 161

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ALAN ULISS, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ketorolac Tromethamine
906
Latanoprost
537
Fluorometholone
402
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
272
Restasis
Cyclosporine
203
Timolol Maleate
162
Brimonidine Tartrate
148
Lumigan
Bimatoprost
137
Prolensa
Bromfenac Sodium
82
Prednisolone Acetate
64

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How ALAN ULISS, M.D. fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

ALAN ULISS, M.D.'s 4,021 claims are above the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as ULISS.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ALAN ULISS, M.D.'s specialty?
ALAN ULISS, M.D. specializes in Retina Specialist (Ophthalmology) Physician and practices in FOREST HILLS, New York. Credentials: M.D..
How much does ALAN ULISS, M.D. prescribe under Medicare Part D?
In 2023, ALAN ULISS, M.D. wrote 4,021 Medicare Part D claims totaling $951K in drug costs for 771 beneficiaries.
What is ALAN ULISS, M.D.'s Medicare quality score?
ALAN ULISS, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ALAN ULISS, M.D. located?
ALAN ULISS, M.D. is located at 11011 72ND AVE, FOREST HILLS, NY, 11375. Phone: (718) 575-8434.
What is ALAN ULISS, M.D.'s NPI number?
ALAN ULISS, M.D.'s National Provider Identifier (NPI) is 1902895998, issued on 10/21/2005.
Does ALAN ULISS, M.D. prescribe more brand-name or generic drugs?
ALAN ULISS, M.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $872K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does ALAN ULISS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ALAN ULISS, M.D.'s most frequently prescribed drugs include Ketorolac Tromethamine, Latanoprost, Fluorometholone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ALAN ULISS, M.D. accept Medicare?
ALAN ULISS, M.D. appears in CMS Medicare data with 4,021 Part D claims and 771 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ALAN ULISS, M.D.'s credentials?
ALAN ULISS, M.D.'s NPI is 1902895998 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology